Life Sciences Investment Banking
An experienced team in a vibrant sector.
Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.
Life Sciences Subsector Expertise
- Biotechnology
- Specialty Pharmaceuticals
Senior Banking Team










Transaction History
Transaction history may include a transaction completed by a Raymond James banker while at a former firm.
Recent News
Investment Banking
|
October 27, 2022
Raymond James adds senior banker to Private Capital Advisory Investment Banking practice
Read more about Raymond James adds senior banker to Private Capital Advisory Investment Banking practice
Public Finance
|
December 7, 2022
Raymond James hires veteran banker Patrick McCarthy as co-head of Healthcare Finance group
Read More about Raymond James hires veteran banker Patrick McCarthy as co-head of Healthcare Finance group
Investment Banking
|
December 5, 2022